|Articles|February 1, 2013
- BioPharm International-02-01-2013
- Volume 26
- Issue 2
BioPharm International, February 2013 Issue (PDF)
Viral Vaccines
Advertisement
Articles in this issue
almost 13 years ago
Assessing Development Needs for Biobetters and Biosimilarsalmost 13 years ago
Facility Design and Operation: A Primeralmost 13 years ago
Offering a Biopharma View of Social Mediaalmost 13 years ago
GMP Compliance Becomes Prominent Enforcement Issuealmost 13 years ago
Therapeutic Antibodies in Reviewalmost 13 years ago
The Vaccine Scenealmost 13 years ago
Automated Concentration and Diafiltration of Multiple siRNA Samplesalmost 13 years ago
End of the Dedicated CMO?almost 13 years ago
Viral Vaccine Manufacturingalmost 13 years ago
Navigating Emerging Markets: Eastern EuropeNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
